Cytometry Part B-Clinical Cytometry

Article	Citations
Issue highlights—January 2025	35
	32
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring	31
An uncommon case of acute megakaryoblastic leukemia with DDX3X::MLLT10 fusion gene	29
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells	24
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease	20
Issue highlights—September 2023	19
	18
	15
Issue Information	15
Issue Information	15
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients	14
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel	14
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa	13
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma	13
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis	12
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia	12
Standardization of flow cytometric detection of antigen expression	12
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia	11
Issue Information	11
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi	11
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia	11
Issue Information	11
Issue Highlights—January 2022	10
Issue Information	10

ROR1 expression in mature B lymphoid neoplasms by flow cytometry	10
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes	9
	9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric	9
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow	9
Issue Information	9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR	8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry	8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT	8
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry	8
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry	7
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays	7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International	7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia	7
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry	6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies	6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis	6
Issue Information	6
	6
	6
Possible alternative strategies to implement basophil activation testing in multicentric studies	5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring	5
	5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry	5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening	5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds	5
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet	5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience	5
Editorial on IVD cellular assay validation	5
Issue Highlights—July 2022	4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD7	4
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome	4
Issue Information	4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup	4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care	4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia	4
Issue Highlights—November 2021	4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases	4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation	4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma	4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis	4
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions	3
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry	3
	3
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms	3
Flow cytometry in the diagnosis of myelodysplastic syndromes	3
Issue highlights—May 2023	3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent	3
Issue highlights—November 2024	3
	3

Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis	3
Issue Highlights—July 2025	3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia	3
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti	3
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder	3
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia	3
The use of erythrocytes as biomarkers with a timeline	3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern	3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease	3
	3
	3
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients	3
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study	3
Issue Information	3
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience	3
Issue Information	3
Issue highlights—July 2024	3
Issue Highlights—March 2022	3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition	3
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy	2
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow	2
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes	2
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients	2
Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41‐positive progenitor cells	2
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands	2
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome	2
The role of CD20+ T cells: Insights in human peripheral blood	2
	2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection	2
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall	2
Issue highlights—September 2024	2
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS	2
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp	2
Noel Warner Ph.D.	2
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia	2
Issue Highlights—September 2022	2
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma	2
Recommendations for using artificial intelligence in clinical flow cytometry	2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow	2
Issue highlights—July 2023	2
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country	2
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders	2
Issue Information	2
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry	2
	1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation	1
Issue Information	1
Issue highlights—November 2022	1
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting	1
Issue highlights—February 2024	1
	1
Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot‐plot based analysis for flow cytometry	1
Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis	1
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor	1
ESCCA/ISCCA survey on the use of multicolor flow cytometry in the detection of cerebrospinal fluid involvement in hematological malignancies: How close does real‐life adhere to t	1
	1
	1
Issue Information	1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry	1
	1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies	1
	1
Acute leukemia of ambiguous lineage, not otherwise specified with FLT3‐ITD mutation and a possible origin in the common lymphoid progenitor	1
Cross‐sectional reassessment after 4 years of clinical routine use of AQUIOS CL for absolute T cell quantitation in a university hospital	1
Human leukocyte antigen‐B27 typing by flow cytometry: Comparison of three CE‐IVD methods	1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia	1
Issue Highlights—September 2021	1
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes	1
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy	1
A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases	1
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry	1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di	1
Automation in flow cytometry: Guidelines and review of systems	1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry	1
Issue Information	1
Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry	1
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm	1
Integrated analysis of genotype and phenotype reveals clonal evolution and cytogenetically driven disruption of myeloid cell maturation in myelodysplastic syndromes	1
Dissecting the sCD3‐CD4+ T‐cell population: A valuable screening tool for angioimmunoblastic T‐cell lymphoma	1
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors	1

Toward immunoprofiling in MDS: A computational study of the bone marrow immune microenvironment	1
Issue Information	1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data	1
CD5‐negative chronic lymphocytic leukemia: Does this entity really exist?	1
Issue Highlights—May 2022	1